Control of a cell lymphoma recognition via natural killer inhibitory receptors implies a role for human Vγ9/Vδ2 T cells in tumor immunity

European Journal of Immunology

Volumn 27, Issue 12, 1997, Pages 3368-3379

  Fisch, Paul ^a   Meuer, Eva ^b   Pende, Daniela ^c   Rothenfußer, Simon ^c   Viale, Oriane ^c   Kock, Sylvia ^c   Ferrone, Soldano ^d   Fradelizi, Didier ^e   Klein, George ^f   Moretta, Lorenzo ^c   Rammensee, Hans Georg ^a   Boon, Thierry ^g   Coulie, Pierre ^g   Van Der Bruggen, Pierre ^g  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c CENTRO DI BIOTECNOLOGIE AVANZATE   (Italy)

^d NEW YORK MEDICAL COLLEGE   (United States)

^e Hopital Cochin ^*  (France)

^f KAROLINSKA INSTITUTE   (Sweden)

^g UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

T lymphocyte; B cell lymphoma; Natural killer receptor

Indexed keywords

HLA ANTIGEN CLASS 1; T LYMPHOCYTE RECEPTOR; IMMUNOGLOBULIN RECEPTOR; LYMPHOCYTE ANTIGEN RECEPTOR;

ANTIGEN RECOGNITION; ARTICLE; B CELL LYMPHOMA; BURKITT LYMPHOMA; CELL SURFACE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DAUDI CELL; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LYMPHOCYTE CLONE; NATURAL KILLER CELL; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR IMMUNITY; CELL CULTURE; CYTOTOXICITY; IMMUNOLOGY; T LYMPHOCYTE SUBPOPULATION;

CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; KILLER CELLS, NATURAL; LYMPHOMA, B-CELL; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; RECEPTORS, IMMUNOLOGIC; T-LYMPHOCYTE SUBSETS;

EID: 0031283081     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.1830271236     Document Type: Article

References (53)

1. Haas, W., Pereira, P. and Tonegawa, S., Gamma/delta cells. Annu. Rev. Immunol. 1993. 11: 637-685.
2. Mombaerts, P., Arnoldi, J., Russ, F., Tonegawa, S. and Kaufmann, S. H. E., Different roles of αβ and γδ T cells in immunity against an intracellular bacterial pathogen. Nature 1993. 365: 53-56.
3. Kaufmann, S., γδ and other unconventional T lymphocytes: What do they see and what do they do? Proc. Natl. Acad. Sci. USA 1996. 93: 2272-2279.
4. Parker, C. M., Groh, V., Band, H., Porcelli, S. A., Morita, C., Fabbi, M., Glass, D., Strominger, J. L. and Brenner, M. B., Evidence for extrathymic changes in the T cell receptor yo repertoire. J. Exp. Med. 1990. 171: 1597-1612.
5. Constant, P., Davodeau, F., Peyrat, M. A., Poquet, Y., Puzo, G., Bonneville, M. and Fournié, J. J., Stimulation of human γδ T cells by nonpeptidic mycobacterial ligands. Science 1994. 264: 267-270.
6. Burk, M. R., Mori, L. and De Libero, G., Human Vγ9/ Vδ2 cells are stimulated in a cross-reactive fashion by a variety of phosphorylated metabolites. Eur. J. Immunol. 1995. 25: 2052-2058.
7. Tanaka, Y., Morita, C. T., Nieves, E., Brenner, M. B. and Bloom, B. R., Natural and synthetic non-peptide antigens recognized by human γδ T cells. Nature 1995. 375: 155-158.
8. Fisch, P., Malkovsky, M., Braakman, E., Sturm, E., Bolhuis, R. L. H., Prieve, A., Sosman, J. A., Lam, V. A. and Sondel, P. M., γ/δ T cell clones and natural killer cell clones mediate distinct patterns of non-major histocompatibility complex-restricted cytolysis. J. Exp. Med. 1990. 171: 1567-1579.
9. Sturm, E., Braakman, E., Fisch, P., Vreugdenhil, R. J., Sondel, P. and Bolhuis, R. L. H., Human Vγ9/Vδ2 T cell receptor-γδ lymphocytes show specificity to Daudi Burkitt's lymphoma cells. J. Immunol. 1990. 145: 3202-3208.
10. Fisch, P., Malkovsky, M., Kovats, S., Sturm, E., Braakman, E., Klein, B. S., Voss, S. D., Morrissey, L. W., DeMars, R., Welch, W. J., Bolhuis, R. L. H. and Sondel, P. M., Recognition by human Vγ9/Vδ2 T cells of a GroEL homolog on Daudi Burkitt's lymphoma cells. Science 1990. 250: 1269-1273.
11. Davodeau, F., Peyrat, M. A., Hallet, M. M., Gaschet, J., Houde, I., Vivien, R., Vie, H. and Bonneville, M., Close correlation between Daudi and mycobacterial antigen recognition by human γδ T cells and expression of V9JPC1 γ/V2DJC δ-encoded T cell receptors. J. Immunol. 1993. 151: 1214-1223.
12. Bukowski, J. F., Morita, C. T., Tanaka, Y., Bloom, B. R., Brenner, M. B. and Band, H., Vγ2/Vδ2 TCP-dependent recognition of non-peptide antigens and Daudi cells analyzed by TCR gene transfer. J. Immunol. 1995. 154: 998-1006.
13. Panchamoorthy, G., McLean, J., Modlin, R. L., Morita, C. T., Ishikawa, S., Brenner, M. B. and Band, H., A predominance of the T cell receptor Vγ2/Vδ2 subset in human mycobacteria-responsive T cells suggests germ-line gene encoded recognition. J. Immunol. 1991. 147: 3360-3369.
14. Ber, R., Klein, G., Moar, M., Povey, S., Rosen, A., Westman, A., Yefenof, E. and Zeuthen, J., Somatic cell hybrids between human lymphoma lines. IV. Establishment and characterization of a P3HR-1/Daudi hybrid. Int. J. Cancer 1978. 21: 707-719.
15. Zeuthen, J., Klein, G., Ber, R., Masucci, G., Bisballe, S., Povey, S., Terasaki, P. and Ralph, P., Human lymphoma-lymphoma hybrids and lymphoma-leukemia hybrids. I. Isolation, characterization, cell surface markers and B-cell markers. J. Natl. Cancer Inst. 1982. 68: 179-195.
16. Jeffreys, A. J., Wilson, V. and Thein, S. L., Individual-specific 'fingerprints' of human DNA. Nature 1985. 316: 76-79.
17. - T cell receptor-γδ clones from peripheral blood. J. Immunol. 1991. 147: 1180-1188.
18. Viale, O., van der Bruggen, P., Meuer, E., Kunzmann, R., Kohler, H., Mertelsmann, R., Boon, T. and Fisch, P., Recognition by human Vγ9 Vδ2 T cells of melanoma cells upon fusion with Daudi cells. Immunogenetics 1996. 45: 27-34.
19. Quillet, A., Presse, F., Marchiol Fournigault, C., Harel Bellan, A., Benbunan, M., Ploegh, H. and Fradelizi, D., Increased resistance to non-MHC-restricted cytotoxicity related to HLA A, B expression. Direct demonstration using β2-microglobulin-transfected Daudi cells. J. Immunol. 1988. 141: 17-20.
20. Seong, R. H., Clayberger, C. A., Krensky, A. M. and Parnes, J. R., Rescue of Daudi HLA class I expression by transfection with the mouse β2-microglobulin gene. J. Exp. Med. 1988. 167: 288-299.
21. Wang, Z., Hu, X. Z., Tatake, R. J., Yang, S. Y., Zeff, R. A. and Ferrone, S., Differential effect of human and mouse β2-microglobulin on the induction and the antigenic profile of endogenous HLA-A and -B antigens synthesized by β2-microglobulin gene-null FO-1 melanoma cells. Cancer Res. 1993. 53: 4303-4309.
22. Kärre, K., Ljunggren, H. G., Piontek, G. and Kiessling, R., Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 1986. 319: 675-678.
23. Moretta, A., Bottino, C., Vitale, M., Pende, D., Biassoni, R., Mingari, M. C. and Moretta, L., Receptors for HLA class I molecules in human natural killer cells. Annu. Rev. Immunol. 1996. 14: 619-648.
24. + natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition. J. Exp. Med. 1990. 172: 1589-1598.
25. Litwin, V., Gumperz, J., Parham, P., Phillips, J. H. and Lanier, L. L., Specificity of HLA class I antigen recognition by human NK clones: evidence for clonal heterogeneity, protection by self and non-self alleles and influence of the target cell type. J. Exp. Med. 1993. 178: 1321-1336.
26. Colonna, M. and Samaridis, J., Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science 1995. 268: 405-408.
27. Wagtmann, N., Biassoni, R., Cantoni, C., Verdiani, S., Malnati, M. S., Vitale, M., Bottino, C., Moretta, L., Moretta, A. and Long, E. O., Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains. Immunity 1995. 2: 439-449.
28. Pende, D., Biassoni, R., Cantoni, C., Verdiani, S., Falco, M., Di Donato, C., Accame, L., Bottino, C., Moretta, A. and Moretta, L., The natural killer cell receptor specific for HLA A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140 KD disulphide-linked dimer. J. Exp. Med. 1996. 184: 505-518.
29. Ferrini, S., Cambiaggi, A., Meazza, R., Sforzini, S., Marciano, S., Mingari, M. C. and Moretta, L., T cell clones expressing the natural killer cell-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function. Eur. J. Immunol. 1994. 24: 2294-2298.
30. Phillips, J. H., Gumperz, J. E., Parham, P. and Lanier, L. L., Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes. Science 1995. 268: 403-405.
31. Mingari, M. C., Vitale, C., Cambiaggi, A., Schiavetti, F., Melioli, G., Ferrini, S. and Poggi, A., Cytolytic T lymphocytes displaying natural killer (NK)-like activity: expression of NK-related functional receptors for HLA-class I molecules (p58 and CD94) and inhibitory effect on the TCP-mediated target cell lysis or lymphokine production. Int. Immunol. 1995. 7: 697-703.
32. Ikeda, H., Lethé, B., Lehmann, F., Van Baran, N., Baurain, J.-F., De Smet, C., Chambost, H., Vitale, M., Moretta, A., Boon, T. and Coulie, P. G., Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor. Immunity 1997. 6: 199-208.
33. Nakajima, H., Tomiyama, H. and Takiguchi, M., Inhibition of γδ T cell recognition by receptors for MHC class I molecules. J. Immunol. 1995. 155: 4139-4142.
34. + T lymphocytes. I. Inhibition of the IL-2-dependent proliferation by anti-Kp43 monoclonal antibody. J. Immunol. 1990. 144: 3238-3247.
35. Sivori, S., Vitale, M., Bottino, C., Marcenaro, E., Sanseverino, L., Parolini, S., Moretta, L. and Moretta, A., CD94 functions as a natural killer cell inhibitory receptor for different HLA class I alleles; identification of the inhibitory form of CD94 by the use of novel monoclonal antibodies. Eur. J. Immunol. 1996. 26: 2487-2494.
36. Rowe, M., Rowe, D. T., Gregory, C. D., Young, L. S., Farrell, P. J., Rupani, H. and Rickinson, A. B., Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells. EMBO J. 1987. 6: 2743-2751.
37. De Paoli, P., Gennari, D., Martelli, P., Cavarzerani, V., Comoretto, R. and Santini, G., γδ T cell receptor-bearing lymphocytes during Epstein-Barr virus infection. J. Infect. Dis. 1990. 161: 1013-1016.
38. Gattoni Celli, S., Kirsch, K., Timpane, R. and Isselbacher, K. J., β2-microglobulin gene is mutated in a human colon cancer cell line (HCT) deficient in the expression of HLA class I antigens on the cell surface. Cancer Res. 1992. 52: 1201-1204.
39. Wang, Z., Cao, Y., Albino, A. P., Zeff, R. A., Houghton, A. and Ferrone, S., Lack of HLA class I antigen expression by melanoma cells SK-MEL-33 caused by a reading frameshift in β2-microglobulin messenger RNA. J. Clin. Invest. 1993. 91: 684-692.
40. Liao, N. S., Bix, M., Zijlstra, M., Jaenisch, R. and Raulet, D., MHC class I deficiency: susceptibility to natural killer (NK) cells and impaired NK activity. Science 1991. 253: 199-202.
41. Natali, P. G., Nicotra, M. R., Bigotti, A., Venturo, I., Marcenaro, L., Giacomini, P. and Russo, C., Selective changes in expression of HLA class I polymorphic determinants in human solid tumors. Proc. Natl. Acad. Sci. USA 1989. 86: 6719-6723.
42. Imreh, M. P., Zhang, Q. J., de Campos Lima, P. O., Imreh, S., Krausa, P., Browning, M., Klein, G. and Masucci, M. G., Mechanisms of allele-selective down-regulation of HLA class I in Burkitt's lymphoma. Int. J. Cancer 1995. 62: 90-96.
43. Rooney, C. M., Rowe, M., Wallace, L. E. and Rickinson, A. B., Epstein-Barr virus-positive Burkitt's lymphoma cells not recognized by virus-specific T-cell surveillance. Nature 1985. 317: 629-631.
44. Masucci, M. G., Torsteindottir, S., Colombani, J., Brautbar, C., Klein, E. and Klein, G., Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines. Proc. Natl. Acad. Sci. USA 1987. 84: 4567-4571.
45. Klein, G., Epstein-Barr virus strategy in normal and neoplastic B cells. Cell 1994. 77: 791-793.
46. Rowe, M., Khanna, R., Jacob, C. A., Argaet, V., Kelly, A., Powis, S., Belich, M., Croom Carter, D., Lee, S., Burrows, S. R., Trowsdale, J., Moss, D. J. and Rickinson, A. B., Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression. Eur. J. Immunol. 1995. 25: 1374-1384.
47. Levitskaya, J., Coram, M., Levitsky, V., Imreh, S., Steigerwald Mullen, P. M., Klein, G., Kurilla, M. G. and Masucci, M. G., Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature 1995. 375: 685-688.
48. Morita, C. T., Beckman, E. M., Bukowski, J. F., Tanaka, Y., Band, H., Bloom, B. R., Golan, D. E. and Brenner, M. B., Direct presentation of nonpeptide prenyl pyrophosphate antigens to human γδ T cells. Immunity 1995. 3: 495-507.
49. + T cell receptor-α/β-circulating lymphocytes. J. Exp. Med. 1988. 167: 694-699.
50. Bottino, C., Tambussi, G., Ferrini, S., Ciccone, E., Varese, P., Mingari, M. C., Moretta, L. and Moretta, A., Two subsets of human T lymphocytes expressing γ/δ antigen receptor are identifiable by monoclonal antibodies directed to two distinct molecular forms of the receptor. J. Exp. Med. 1988. 168: 491-505.
51. - T lymphocytes. Eur. J. Immunol. 1989. 19: 57-61.
52. Espevik, T. and Nissen Meyer, J., A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/ tumor necrosis factor from human monocytes. J. Immunol. Methods 1986. 95: 99-105.
53. Traversari, C., van der Bruggen, P., Van den Eynde, B., Hainaut, P., Lemoine, C., Ohta, N., Old, L. and Boon, T., Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes. Immunogenetics 1992. 35: 145-152.